The COVID-19 pandemic brought knee and hip replacements to a virtual halt because they aren’t usually considered emergency procedures. But they are profitable, and hospital systems are now counting on the surgeries to help restore their financial health.
Starting in August 2020, a new episode every other week. No time like a pandemic to learn more about how to fight the high cost of health care.
Starting in August 2020, a new episode every other week. No time like a pandemic to learn more about how to fight the high cost of health care.
Half of the money the Trump administration gave dialysis companies was collected by Fresenius, an international juggernaut with a robust balance sheet, a KHN analysis has found.
Half of the money the Trump administration gave dialysis companies was collected by Fresenius, an international juggernaut with a robust balance sheet, a KHN analysis has found.
Skeptics say the lack of enforceable federal safety standards geared toward the coronavirus allows these employers to prioritize the harvest over worker safety.
Skeptics say the lack of enforceable federal safety standards geared toward the coronavirus allows these employers to prioritize the harvest over worker safety.
President Donald Trump keeps promising a comprehensive plan to replace the Affordable Care Act. And he keeps not delivering. Meanwhile, members of Congress and White House officials seem unable to agree on a new COVID-19 relief bill. And Missouri becomes the sixth state where voters approved a Medicaid expansion ballot measure. Tami Luhby of CNN, Alice Miranda Ollstein of Politico and Kimberly Leonard of Business Insider join KHN’s Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Harvard research shows minorities are most likely to report inadequate PPE and to work with COVID-positive patients.
Vaccines engineered to protect the public from influenza, hepatitis B, tetanus and rabies are less effective for obese people, leaving them more vulnerable to serious illness. As scientists race to develop a COVID-19 vaccine, experts say obesity could prove an impediment — a sobering prospect for a nation in which nearly half of all adults are obese.
